LAUSR

Up‐to‐date information on the prevalence and trends of common mental disorders is relevant to health care policy and planning, owing to the high burden associated with these disorders. In the first wave of the third Netherlands Mental Health Survey and Incidence Study (NEMESIS‐3), a nationally representative sample was interviewed face‐to‐face from November 2019 to March 2022 (6,194 subjects; 1,576 interviewed before and 4,618 during the COVID‐19 pandemic; age range: 18‐75 years). A slightly modified version of the Composite International Diagnostic Interview 3.0 was used to assess DSM‐IV and DSM‐5 diagnoses. Trends in 12‐month prevalence rates of DSM‐IV mental disorders were examined by comparing these rates between NEMESIS‐3 and NEMESIS‐2 (6,646 subjects; age range: 18‐64 years; interviewed from November 2007 to July 2009). Lifetime DSM‐5 prevalence estimates in NEMESIS‐3 were 28.6% for anxiety disorders, 27.6% for mood disorders, 16.7% for substance use disorders, and 3.6% for attention‐deficit/hyperactivity disorder. Over the last 12 months, prevalence rates were 15.2%, 9.8%, 7.1%, and 3.2%, respectively. No differences in 12‐month prevalence rates before vs. during the COVID‐19 pandemic were found (26.7% pre‐pandemic vs. 25.7% during the pandemic), even after controlling for differences in socio‐demographic characteristics of the respondents interviewed in these two periods. This was the case for all four disorder categories. From 2007‐2009 to 2019‐2022, the 12‐month prevalence rate of any DSM‐IV disorder significantly increased from 17.4% to 26.1%. A stronger increase in prevalence was found for students, younger adults (18‐34 years) and city dwellers. These data suggest that the prevalence of mental disorders has increased in the past decade, but this is not explained by the COVID‐19 pandemic. The already high mental disorder risk of young adults has particularly further increased in recent years.